Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Generic drugs
Pharma
Troubled Mallinckrodt, Endo telegraph $6.7B merger plans
After grappling with bankruptcy bids and opioid settlements, Endo and Mallinckrodt are uniting to carve out a brighter future as a combined company.
Fraiser Kansteiner
Mar 13, 2025 10:18am
Tariffs could bring price hikes, threaten supplies: trade groups
Feb 3, 2025 11:00am
Teva's subdued outlook puts damper on strong 2024 results
Jan 29, 2025 1:13pm
Catalyst's Teva settlement postpones arrival of Firdapse generic
Jan 9, 2025 10:08am
Deloitte outlines key areas for biopharma to watch in 2025
Dec 26, 2024 8:00am
BMS, Merck, Amgen and more face near-term generic woes: Leerink
Nov 13, 2024 10:57am
